XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
(Accumulated Deficit) Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Common Stock (Class A)
Common Stock
Common Stock (Class B)
Common Stock
Beginning balance (in shares) at Feb. 03, 2024           22,714 7,306
Beginning balance at Feb. 03, 2024 $ 144,869 $ 30 $ 172,478 $ (27,962) $ 323    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (32,565)     (32,565)      
Restricted stock (in shares)           61  
Share-based compensation expense 1,744   1,744        
Employee stock option exercises (in shares)           71  
Employee stock option exercises 294   294        
Net change in unrealized (loss) gain on available-for-sale securities (31)       (31)    
Ending balance (in shares) at Nov. 02, 2024           22,846 7,306
Ending balance at Nov. 02, 2024 114,311 30 174,516 (60,527) 292    
Beginning balance (in shares) at Aug. 03, 2024           22,846 7,306
Beginning balance at Aug. 03, 2024 126,773 30 173,939 (47,652) 456    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (12,875)     (12,875)      
Share-based compensation expense 577   577        
Net change in unrealized (loss) gain on available-for-sale securities (164)       (164)    
Ending balance (in shares) at Nov. 02, 2024           22,846 7,306
Ending balance at Nov. 02, 2024 114,311 30 174,516 (60,527) 292    
Beginning balance (in shares) at Feb. 01, 2025           22,846 7,306
Beginning balance at Feb. 01, 2025 100,871 30 174,829 (74,191) 203    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (20,394)     (20,394)      
Restricted stock (in shares)           322  
Share-based compensation expense 1,343   1,343        
Net change in unrealized (loss) gain on available-for-sale securities (203)       (203)    
Ending balance (in shares) at Nov. 01, 2025           23,168 7,306
Ending balance at Nov. 01, 2025 81,617 30 176,172 (94,585) 0    
Beginning balance (in shares) at Aug. 02, 2025           23,168 7,306
Beginning balance at Aug. 02, 2025 82,500 30 175,648 (93,178) 0    
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (1,407)     (1,407)      
Share-based compensation expense 524   524        
Net change in unrealized (loss) gain on available-for-sale securities 0            
Ending balance (in shares) at Nov. 01, 2025           23,168 7,306
Ending balance at Nov. 01, 2025 $ 81,617 $ 30 $ 176,172 $ (94,585) $ 0